Alaunos Therapeutics Analyst Ratings
Alaunos Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/16/2023 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
| 08/15/2023 | — | Laidlaw & Co. | Downgrades | Buy → Hold | |
| 05/15/2023 | 979.14% | HC Wainwright & Co. | → $1.5 | Upgrades | Neutral → Buy |
| 03/27/2023 | 2058.27% | Wells Fargo | → $3 | Assumes | → Overweight |
| 10/04/2022 | 2058.27% | Wells Fargo | → $3 | Assumes | → Overweight |
| 07/15/2022 | 2058.27% | Cantor Fitzgerald | → $3 | Assumes | → Overweight |
| 05/04/2022 | 2058.27% | Wells Fargo | → $3 | Upgrades | Equal-Weight → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 08/16/2023 | - | HC Wainwright公司 | 評級下調 | 購買→中性 | |
| 2023年08月15日 | - | 萊德勞公司 | 評級下調 | 購買→Hold | |
| 2023年05月15日 | 979.14% | HC Wainwright公司 | →$1.5 | 升級 | 中性→購買 |
| 03/27/2023 | 2058.27% | 富國銀行 | →$3 | 假設 | →超重 |
| 10/04/2022 | 2058.27% | 富國銀行 | →$3 | 假設 | →超重 |
| 07/15/2022 | 2058.27% | 康託·菲茨傑拉德 | →$3 | 假設 | →超重 |
| 05/04/2022 | 2058.27% | 富國銀行 | →$3 | 升級 | 等重→超重 |
What is the target price for Alaunos Therapeutics (TCRT)?
ALaunos治療公司(TCRT)的目標價格是多少？
The latest price target for Alaunos Therapeutics (NASDAQ: TCRT) was reported by HC Wainwright & Co. on August 16, 2023. The analyst firm set a price target for $0.00 expecting TCRT to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
納斯達克治療公司(納斯達克代碼：TCRT)的最新目標價是由HC Wainwright&Co.於2023年8月16日報道的。這家分析公司將目標價定為0.00美元，預計TCRT將在12個月內下跌(可能下跌100.00%)。去年有5家分析公司公佈了評級。
What is the most recent analyst rating for Alaunos Therapeutics (TCRT)?
ALaunos治療公司(TCRT)的最新分析師評級是多少？
The latest analyst rating for Alaunos Therapeutics (NASDAQ: TCRT) was provided by HC Wainwright & Co., and Alaunos Therapeutics downgraded their neutral rating.
納斯達克(代碼：TCRT)的最新分析師評級由HC Wainwright&Co.提供，ALaunos治療公司下調了中性評級。
When is the next analyst rating going to be posted or updated for Alaunos Therapeutics (TCRT)?
ALaunos治療公司(TCRT)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alaunos Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alaunos Therapeutics was filed on August 16, 2023 so you should expect the next rating to be made available sometime around August 16, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與ALaunos Treeutics的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。ALaunos治療公司的上一次評級是在2023年8月16日提交的，所以你應該預計下一次評級將在2024年8月16日左右提供。
Is the Analyst Rating Alaunos Therapeutics (TCRT) correct?
分析師對ALaunos Treeutics(TCRT)的評級正確嗎？
While ratings are subjective and will change, the latest Alaunos Therapeutics (TCRT) rating was a downgraded with a price target of $0.00 to $0.00. The current price Alaunos Therapeutics (TCRT) is trading at is $0.14, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的ALaunos治療公司(TCRT)評級被下調，目標價為0.00美元至0.00美元。ALaunos治療公司(TCRT)目前的交易價格為0.14美元，超出了分析師的預測範圍。